TAKE

TAKE Limited

Life sciences and supply chain technology solutions provider

Healthcare›Healthcare›Healthcare Services›Healthcare Research, Analytics & Technology

takelimited.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹12.58
Market cap
186 Cr
Stock P/E
14.5
P/B
6.00
Dividend yield
0.0%
ROE (FY26)
35.0%
ROCE (FY26)
36.6%
Operating margin (FY26)
-3.5%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

TAKE (TAKE Limited, formerly TAKE Solutions) is a Chennai-registered technology company that describes itself as serving the life sciences and supply chain industries, and in 2026 it began building consumer longevity, nutraceutical and digital health offerings in India.

Company snapshot

5thBy market cap

Ranked among 5 companies in Healthcare Research, Analytics & Technology.

Segment mix

Reportable segments as of 2022-03-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 100.0% of revenue

SegmentRevenue shareRevenuePBTAssets
Life Sciences
100.0%
41 Cr456 Cr0 Cr
Supply Chain Management—0 Cr0 Cr0 Cr

What we see

Positives
  • ✓Net margin of 20.0% — the business keeps a healthy share of every rupee it earns.
Concerns
  • ✗Interest coverage of -5.5x — earnings barely cover interest payments, which is a warning sign.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 20251Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales18 Cr17 Cr13 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr54 Cr30 Cr
Operating expenses (approx.)16 Cr16 Cr28 Cr2 Cr1 Cr3 Cr1 Cr0.77 Cr0.29 Cr0.35 Cr55 Cr31 Cr
EBITDA2 Cr1 Cr-15 Cr-2 Cr-1 Cr-3 Cr-1 Cr-0.77 Cr-0.29 Cr-0.35 Cr-0.82 Cr-0.26 Cr
OPM %10.0%6.7%-115.2%———————-1.5%-0.9%
Other income0.14 Cr1 Cr0.07 Cr0 Cr0 Cr9 Cr2 Cr0.04 Cr0 Cr1 Cr5 Cr1 Cr
Interest1 Cr1 Cr1 Cr0.49 Cr0.50 Cr0.73 Cr0.24 Cr0.17 Cr0.17 Cr0.0009 Cr0 Cr0.0007 Cr
Depreciation2 Cr2 Cr2 Cr0.01 Cr0.01 Cr0.01 Cr0.01 Cr0.0020 Cr0.0020 Cr0.0020 Cr0.0020 Cr0.0002 Cr
Profit before tax-2 Cr-0.95 Cr-111 Cr-4 Cr-2 Cr48 Cr-5 Cr-0.91 Cr6 Cr1 Cr4 Cr1 Cr
Tax %3.8%-123.9%0.1%-1.9%5.8%0.0%—0.0%2.5%0.0%0.0%0.0%
Net profit-2 Cr-2 Cr-111 Cr-4 Cr-2 Cr48 Cr-5 Cr-0.91 Cr6 Cr1 Cr4 Cr1 Cr
EPS (₹)₹-0.11₹-0.15₹-7.56₹-0.26₹-0.11₹3.26—₹-0.06₹0.43₹0.07₹0.29₹0.07
  1. 1Mar 2025: Derived from year-to-date: the year to 31 Mar 2025 less the quarters to 30 Jun 2024, 30 Sep 2024 and 31 Dec 2024; the filing gives no figures for this quarter alone

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,345 Cr1,587 Cr2,039 Cr2,213 Cr774 Cr655 Cr189 Cr66 Cr0 Cr54 CrSign in free for the trailing twelve months
Operating expenses (approx.)1,082 Cr1,281 Cr1,656 Cr2,044 Cr847 Cr648 Cr208 Cr79 Cr7 Cr56 CrSign in free for the trailing twelve months
EBITDA262 Cr306 Cr383 Cr169 Cr-73 Cr7 Cr-19 Cr-13 Cr-7 Cr-2 CrSign in free for the trailing twelve months
OPM %19.5%19.3%18.8%7.6%-9.4%1.1%-10.1%-20.5%—-3.5%Sign in free for the trailing twelve months
Other income13 Cr6 Cr11 Cr26 Cr12 Cr17 Cr8 Cr2 Cr10 Cr7 CrSign in free for the trailing twelve months
Interest23 Cr21 Cr25 Cr41 Cr37 Cr29 Cr7 Cr5 Cr2 Cr0.35 CrSign in free for the trailing twelve months
Depreciation87 Cr104 Cr154 Cr167 Cr115 Cr80 Cr17 Cr8 Cr0.04 Cr0.0081 CrSign in free for the trailing twelve months
Profit before tax165 Cr188 Cr216 Cr-13 Cr-436 Cr-771 Cr-99 Cr-118 Cr37 Cr11 CrSign in free for the trailing twelve months
Tax %11.4%15.0%17.3%15.3%-3.3%-1.5%-1.7%-1.0%-0.1%1.5%Sign in free for the trailing twelve months
Net profit146 Cr160 Cr178 Cr-11 Cr-450 Cr-782 Cr-100 Cr-120 Cr37 Cr11 CrSign in free for the trailing twelve months
EPS (₹)₹11.22₹12.19₹12.13₹-0.85₹-30.91₹-53.50₹-6.86₹-8.18₹2.56₹0.74Sign in free for the trailing twelve months
Dividend payout %————————0.1%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital13 Cr15 Cr15 Cr15 Cr15 Cr15 Cr15 Cr15 Cr15 Cr15 Cr
Reserves898 Cr1,314 Cr1,504 Cr1,561 Cr1,110 Cr166 Cr94 Cr-23 Cr6 Cr16 Cr
Borrowings221 Cr308 Cr455 Cr514 Cr450 Cr45 Cr33 Cr28 Cr——
Other liabilities199 Cr199 Cr351 Cr384 Cr270 Cr997 Cr83 Cr69 Cr16 Cr5 Cr
Total liabilities1,373 Cr1,844 Cr2,334 Cr2,483 Cr1,845 Cr1,223 Cr224 Cr88 Cr36 Cr36 Cr
Fixed assets (net)162 Cr213 Cr264 Cr290 Cr194 Cr28 Cr8 Cr22 Cr0 Cr0 Cr
CWIP6 Cr0.77 Cr1 Cr0.77 Cr0.21 Cr3 Cr10 Cr—0 Cr—
Investments10 Cr59 Cr10 Cr17 Cr7 Cr—0 Cr0 Cr0 Cr0 Cr
Inventories17 Cr17 Cr18 Cr3 Cr0.60 Cr0.65 Cr0.78 Cr0.80 Cr0 Cr0 Cr
Trade receivables436 Cr469 Cr525 Cr701 Cr434 Cr82 Cr30 Cr7 Cr0 Cr0.22 Cr
Cash & bank74 Cr317 Cr47 Cr45 Cr39 Cr29 Cr11 Cr0.84 Cr3 Cr0.26 Cr
Other assets667 Cr768 Cr1,469 Cr1,426 Cr1,169 Cr1,081 Cr164 Cr58 Cr33 Cr36 Cr
Total assets1,373 Cr1,844 Cr2,334 Cr2,483 Cr1,845 Cr1,223 Cr224 Cr88 Cr36 Cr36 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity56 Cr104 Cr104 Cr211 Cr135 Cr30 Cr20 Cr9 Cr-16 Cr-4 Cr
Cash from investing-129 Cr-179 Cr-485 Cr-236 Cr-57 Cr-31 Cr-2 Cr-7 Cr22 Cr2 Cr
Cash from financing56 Cr318 Cr100 Cr21 Cr-84 Cr-55 Cr-36 Cr-12 Cr-3 Cr-0.72 Cr
Net cash flow-17 Cr244 Cr-281 Cr-4 Cr-6 Cr-55 Cr-18 Cr-10 Cr3 Cr-3 Cr
Free cash flow (OCF − Capex)-92 Cr-42 Cr-89 Cr29 Cr132 Cr-2 Cr12 Cr1 Cr-16 Cr-4 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %16.0%12.7%12.1%1.4%-25.3%-328.2%-64.3%-111.9%191.9%36.6%
ROE %15.0%12.0%11.6%-0.8%-40.0%-433.1%-92.3%—182.5%35.0%
Debtor days11810894116204455839—1
Inventory days5133211312—0
Days payable12393348054104260—9
Cash conversion cycle110829484125-7-42-209—-7
OCF / EBITDA %21.3%33.9%27.0%125.0%—n.m.————
OCF / EBITDA % (3 years)——27.7%48.8%93.9%n.m.————
Debt / equity0.240.230.300.330.400.250.31———
Current ratio2.322.841.621.821.641.080.890.401.484.54
Net debt / EBITDA0.56—1.07———————